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Abstract: The aim of this study was to
investigate the role of NO in the pathogenesis
of lung injury associated with pancreatitis, and
the relation between malondialdehyde (MDA)
and myeloperoxidase (MPO). Forty Wistar
male rats were divided into control or
pancreatitis groups, and treated with saline,
L-arginine (100 mg/kg i.v.), NO donor, or Nnitro-L-arginine methyl ester (L-NAME) (10
mg/kg i.v.), an inhibitor of NO synthase.
Pancreatitis was induced in rats intravenously
via the administration of cerulein (10 µg/kg/h)
for 4 h). Eight hours after the induction of
acute pancreatitis (AP), amylase and lipase in
plasma significantly increased in all animals in
which mild pancreatitis was induced in
comparison with the control group. Cerulein
induced gross pancreatic and lung edema as
reflected by an increase in the wet/dry ratio.
L-arginine significantly decreased pancreatic
and lung edema. L-arginine treatment
prevented the increase of MDA levels in the
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Introduction
Acute pancreatitis is an autodigestive inflammatory
process. Following initial tissue injury, neutrophils
migrate to the area, become activated and initiate a series
of events. Neutrophils and alveolar macrophages release
mediators such as platelet-activating factor, leukotrienes,
nitric oxide (NO), tumor necrosis factor (TNF) and
interleukin (IL)s, which play a role in the evolution of the
local pancreatic inflammation to systemic complications
culminating in multiple organ failure (1-4). Although NO
was originally discovered in the vascular endothelium, it is
synthesized in a variety of cells including macrophages,
platelets and pancreatic cells by the enzyme nitric oxide
synthase (NOS) from the amino acid L-arginine. Various
pharmacological agents may suppress NO synthesis by
G
inhibiting NOS. Arginine analogs such as N -monomethylG
L-arginine (L-NMMA), N nitro-L-arginine (L-NNA) and

pancreas (760 ± 252 nM/g tissue) and lung
(520 ± 188 nM/g tissue). In contrast, LNAME increased MDA levels in the pancreas
(3280 ± 474 nM/g tissue) and lung (2650 ±
411 nM/g tissue). Compared with the AP
group, MPO activity was reduced by Larginine (17.2 ± 3.7 U/g pancreas versus 6.2
± 2.2 U/g pancreas; 28.4 ± 3.3 U/g lung
versus 11.1 ± 3.0 U/g lung). In contrast, LNAME treatment significantly increased MPO
levels in the pancreas (32.8 ± 4.7 U/g
pancreas) and lung (43.7 ± 7.1 U/g lung). In
conclusion, L-arginine treatment improved the
course of mild pancreatitis and prevented lung
injury. Lung injury was aggravated by the
administration of the NO inhibitor L-NAME.
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NG-nitro-L-arginine-methylester (L-NAME) strongly block
NO synthesis (5). Because NO participates in the
modulation of vascular tone and leukocyte function, its
role in acute pancreatitis has been investigated. NO has
been shown to have protective effects by preventing
neutrophil adhesion and regulating microcirculation in
experimental pancreatitis in rats (6-8). However, the role
of NO in the most frequent systemic complication, lung
injury, is unclear. In studies on lung damage in acute
pancreatitis, the secretory agent cerulein is usually used
because the model, which is characterized by edema and
hyperamylasemia, is very appropriate (9). The lung injury
induced is very similar to the early stages of the adult
respiratory distress syndrome (ARDS) (1,10). In this
experimental study, we aimed to investigate the still
controversial role of NO in lung injury due to ceruleininduced pancreatitis.

* Presented, in part, at the 4th World Congress International Hepato-Pancreato-Biliary Association, May 28-June 1, 2000, Brisbane, Australia

463

Protective Effect of Nitric Oxide in Lung Injury Associated with Cerulein-Induced Acute Pancreatitis

Materials and Methods

Animal preparation. Experiments were performed in
40 male Wistar rats weighing 250 to 300 g. All animals
were fasted overnight before the experiments and had
free access to water. Care was provided in accordance
with the procedures outlined in the “Guide for Care and
Use of Laboratory Animals” (National Institutes of Health
Publication no. 85-23, 1985). The study was approved
by the subcommittee on animal research at our
institution.
Surgical anesthesia was induced by
subcutaneous administration of ketamine hydrochloride
100 mg/kg body weight. Polyethylene catheters (0.20
mm internal diameter) were inserted by cutdown into the
right jugular vein. The catheters were tunneled
subcutaneously to the dorsal cervical region and exited
through a steel tether, which permitted free movement.
The animals were randomly divided between a control
group (n = 10) and groups at various treatment of acute
pancreatitis. Acute mild edematous pancreatitis was
induced by continuous individual i.v. infusions of cerulein
(Sigma Chemical, St. Louis, MO) at 10 µg/kg/h over 4 h.
Acute pancreatitis groups were treated with saline (AP
group, n = 10); L-arginine, NO donor, (L-arginine group,
n = 10); and L-NAME, an NOS inhibitor, (L-NAME group,
n = 10). L-arginine and L-NAME were administered 30
min after the initiation of cerulein infusion. L-arginine
(100 mg/kg bolus, Merck & Co., NJ) and L-NAME (10
mg/kg bolus, Sigma Chemical, St. Louis, MO) were
infused intravenously. Animals were killed using an intraarterial pentobarbital overdose (200 mg/kg) 8 h after the
induction of pancreatitis, and a 5 ml blood sample from
the heart was obtained. The pancreas and lungs were
rapidly excised, weighed, and processed for individual
assays.
Amylase and Lipase Measurement. Plasma amylase
and lipase were determined by using commercial kits
from Boehringer-Mannheim (Mannheim, Germany)
according to the supplier’s specifications.
Assessment of Pancreatic and Lung Edema. Pancreatic
water content was determined by calculating the ratio
(wet/dry ratio) from the initial weight of the pancreas
(wet weight) to its weight after incubation at 160 °C for
24 h (dry weight). The wet/dry ratio of lung was
determined in the same fashion.
Malondialdehyde Assay. Serum malondialdehyde
(MDA) was estimated using the thiobarbituric acid
method described by Ohkawa et al. (11).
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Myeloperoxidase Assay. The previously frozen
pancreas and lung tissues were homogenized for 30 sec
in 4 mL of 20-mmol/L potassium phosphate buffer, pH
7.4 and centrifuged for 30 min at 40,000 g at 4 °C. The
pellet was resuspended in 4 mL of 50-mmol/L potassium
phosphate buffer, pH 6.0, containing 0.5 g/dL of
hexadecyltrimethyl ammonium bromide. Samples were
sonicated for 90 sec at full power, incubated in a 60 °C
water bath for 2 h, and centrifuged. The supernatant
(0.1 mL) was added to 2.9 mL of 50 mmol/L potassium
phosphate buffer, pH 6.0, containing 0.167 mg/mL odianisidine and 0.0005% hydrogen peroxide. Absorbance
of 460 nm of visible light (A460) was measured for 3
min. Myeloperoxidase (MPO) activity is expressed as units
per gram of tissue.
Statistical Analysis. All results are expressed as mean
± SD. Differences between groups were compared using
a one-way analysis of variance. The Mann-Whitney test
was performed to evaluate significant differences
between the groups. Differences were assumed to be
significant at p < 0.05.
Results
The plasma amylase and lipase levels are shown in
Table 1. The induction of acute pancreatitis was
confirmed by the rise in amylase and lipase levels (p <
0.001). L-arginine treatment reduced plasma amylase
and lipase levels but did not approach statistical
significance. L-NAME administration did not cause
significant changes in plasma amylase or lipase levels (p >
0.05). The wet weight/dry weight ratio of the pancreas
and the lungs in the pancreatitis groups were significantly
higher in comparison with the control group (Figs. 1 and
2). Although L-arginine and L-NAME treatments
decreased the degree of edema, the change reached
statistical significance only in the L-arginine group (p <
0.001 for pancreas, p < 0.005 for lung).
MDA, a quantitative marker of lipid peroxidation, was
measured in the pancreas and lung. Induction of
pancreatitis caused significant increases in the tissue
levels of MDA (Table 2). L-arginine treatment decreased
tissue MDA levels to the control levels, whereas L-NAME
aggravated lipid peroxidation. The decrease in the tissue
MDA levels in the L-arginine group was statistically
significant (p < 0.001).
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Plasma amylase (U/L)
Plasma lipase (U/L)

Table 1.

Control

AP

L-arginine

L-NAME

234 ± 52
14 ± 6

2502 ± 370*
471 ± 35*

2128 ± 452*
433 ± 44*

2744 ± 434*†
502 ± 51*†

Plasma amylase and lipase levels.

*p < 0.001 vs. control
†p < 0.01 vs. L-arginine
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Figure 1.
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Pancreatic water content.
* p < 0.001 vs. control
† p < 0.001 vs. L-arginine

Pancreas (nM/g tissue)
Lung (nM/g tissue)

Figure 2.

AP

L-arginine L-NAME

Lung water content.
* p < 0.001 vs. control
† p < 0.005 vs. L-arginine

Control

AP

L-arginine

L-NAME

427 ± 187
287 ± 125

2184 ± 578*†
1950 ± 675*†

760 ± 252*
520 ± 188*

3280 ± 474*†
2650 ± 411*†

Table 2.

Malondialdehyde
levels
pancreatic and lung tissue.

in

*p < 0.01 vs. control
†p < 0.001 vs. L-arginine

The degree of neutrophil infiltration in the pancreas
and lung is shown in Table 3. As expected, induction of
pancreatitis causes significant increases in neutrophil
infiltration in both organs. In comparison with the control
group, lung MPO levels were increased in all rats with
acute pancreatitis (p < 0.05). L-arginine treatment
significantly suppressed the increase in MPO levels in the
pancreas and lung (p < 0.001). In contrast, L-NAME
treatment significantly increased MPO levels in the
pancreas and lung (p < 0.001)

Discussion
Acute pancreatitis is a pathophysiological process
initiated by acinar cell damage due to released proteolytic
enzymes. In response to acinar cell damage, cytokines are
released and the complement system is activated. These

molecules cause further releases of cytokines, free
radicals and vasoactive substances such as NO (1,2,12). In
addition to local effects such as edema and necrosis in the
pancreas, these mediators induce systemic effects such as
hypotension, tachycardia, capillary leakage and hypoxia.
They may also trigger apoptosis and necrosis (2). Most
studies have attempted to elucidate the relationships in
this series of events and modulate the pancreatitis
cascade. NO, which has a regulatory role in many organs,
is a reactive free radical that is produced excessively by an
endogenous inducible form of NOS (iNOS) during
inflammatory processes such as acute pancreatitis. In an
experimental model of acute pancreatitis in rats, it has
been shown that increased NO levels due to induction of
iNOS aggravate oxidative damage and this is associated
with arterial hypotension (13). Satoh et al. have
emphasized that iNOS response varies between
465
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Pancreas (U/g tissue)
Lung (U/g tissue)

Control

AP

L-arginine

L-NAME

4.75 ± 2.1
8.3 ± 2.4

17.2 ± 3.7*†
28.4 ± 3.3*†

6.2 ± 2.2
11.1 ± 3.0*

32.8 ± 4.7*†
43.7 ± 7.1*†

Table 3.

Myeloperoxidase activity in the
pancreas and lung.

* p < 0.05 vs. control
† p < 0.001 vs. L-arginine

pancreatitis models and reported that, in necrotizing
pancreatitis, various soluble factors activate the
macrophage/monocyte system and cause increased NO
production by iNOS (14). NO donors and inhibitors have
been used in experimental studies to investigate the role
of NO in acute pancreatitis. Masamune et al. have argued
that the role of NO in acute pancreatitis is limited to
endothelial activation and inhibition of leukocyte
activation (15). In another study on lipopolysaccharideinduced pancreatitis, NO caused a fall in TNF-α levels
whereas L-NNA caused a rise; these results suggest a
protective role of NO (16). Other studies have shown that
NO plays an important role in the preservation of
microcirculation (6,7). Werner et al. have reported
beneficial effects of NO donors on pancreatic perfusion,
leukocyte-endothelium interaction, platelet aggregation
and acinar cell damage in acute pancreatitis (17).
Activated leukocytes play a significant role in the
aggravation of pancreatitis and development of
complications. There is an acute release of oxygen free
radicals from activated neutrophils (1,2,18). MDA is an
end product of lipid peroxidation induced by free oxygen
radicals. Increased plasma and tissue MDA levels reflect
increased free radical production and give information on
the magnitude of tissue damage. In our study, we
investigated the role of NO in cerulein-induced acute
pancreatitis. The increased plasma amylase and lipase
levels as well as edema in pancreatic tissue confirmed the
applicability of the model. Pancreatic tissue MDA levels,
which reflect tissue damage, were significantly increased
in all rats with acute pancreatitis. L-arginine treatment
decreased pancreas MDA levels, whereas L-NAME
increased pancreas MDA levels. In order to evaluate
leukocyte infiltration in pancreatic tissue, we used a
standard marker MPO. Leukocyte infiltration was
significantly more severe in acute pancreatitis. L-arginine
suppressed the leukocyte infiltration, whereas L-NAME
had a reverse effect.
Although acute pancreatitis is a local inflammation, it
has significant systemic effects, the most important of
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which is lung injury. Organ dysfunction develops in
approximately one fourth of all cases and 60% of the
deaths in the first week are due to pulmonary
complications (19). However, the pathogenesis of
pulmonary complications in acute pancreatitis remains
unclear. Several factors have been implicated: mechanical,
alteration in capillary permeability, and pulmonary
microembolization. Guice et al. have reported that in a
hypersecretion model of acute pancreatitis the increased
capillary permeability and interstitial edema in acute
pancreatitis are histologically indistinguishable from
ARDS (10). Neutrophils release specific proinflammatory
mediators and play a definitive role in ARDS. Although
neutrophil activation and aggregation in the lungs
comprise the final common pathway leading to lung
damage, the initial triggering event is controversial.
Complement system activation and proinflammatory
factors from alveolar macrophages are putative
candidates. Alveolar macrophages have the capacity to
mobilize large numbers of leukocytes and secrete
cytokines, arachidonic acid metabolites and NO (20). The
protective anti-inflammatory role of L-arginine or NO in
the lung has been evaluated in a number of studies.
Previous investigations have demonstrated that Larginine or NO decreases alveolar macrophage
proinflammatory cytokine (TNF-α, IL-1β) production
(21) and prevents alveolar edema (22). Sheridan et al.
found that L-arginine decreases lipopolysaccharideinduced
polymorphonuclear
neutrophil
(PMN)
accumulation and attenuates acute lung injury in a rat
model of endotoxemia (23). The capacity of alveolar
macrophages to mobilize a large amount of PMN and to
release secretory products such as cytokines, arachidonic
acid metabolites, and NO after their activation in the
course of different pulmonary inflammatory diseases
suggests that these cells could be involved in the lung
damage associated with acute pancreatitis. The activation
of alveolar macrophages seems to be regulated by
cytokines and inflammatory mediators, which are
reportedly generated during the course of acute
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pancreatitis. In our study, we found that L-arginine
treatment attenuated both MDA and MPO production in
the lung tissue, whereas L-NAME had the opposite effect.
Our findings corroborate those of a previously reported
study (24) regarding the effects of NO pulmonary
neutrophil reflux and the prevention of lung damage in
acute pancreatitis-induced lung injury.
In conclusion, this experimental study shows the
protective role of L-arginine in a model of acute
pancreatitis associated with lung injury. The provision of
L-arginine early in the course of acute pancreatitis may

act to downregulate the inflammatory response via a NOdependent mechanism before the lung damage that
occurs as the result of PMN accumulation and free radical
production.
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